Tyler Cowen

And at least not yet has the magic been dissipated.

So I'm less pessimistic than some people are, but I absolutely do see the dangers.

We're just the biggest market, the freest place.

We have by far the most ambitious people.

I think that's actually the most significant factor.

And young people sense that and they just want to come here.

And there's not really another place they can go that will fit them.

I hope AI lowers costs.

As you probably know, at ARC, they had Greg Brockman come in for some number of months.

And he's one of the people, well, he helped build up Stripe, but he also was highly significant at OpenAI behind the GPT-4 model.

And to have Greg Brockman at your institute doing AI for, what, six months?

That's a massive acceleration.

But actually, no university had the wisdom to do, and ARC did.

So I think we're seeing just more entrepreneurial thinking in the area.

There's still this problem of bottlenecks.

So let's say AI is great for drug discovery, as it may be.

Well, clinical trials then become a bigger bottleneck.

The FDA becomes a bigger bottleneck.

So rapid improvement in only one area, while great, is actually not good enough.

Art can move very quickly.